$609.48

+2.81 (+0.46%) Today
1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

2 Years 2Y

5 Years 5Y

Max Max

More News

Helicobacter Pylori Diagnostics Market 2021-2026 Global Impact & Growth Analysis : Sekisui Diagnostics, F. Hoffmann-La Roche, Medline Industries, Meridian Bioscience, Bio-Rad Laboratories Jun 15, 2021

The research report with title Global Helicobacter Pylori Diagnostics Market Research Report 2021 announced by Courant Market Research proposes an analysis of the Helicobacter Pylori Diagnostics Industry comprising of significant information related to different product definitions, market classifications, geographical presence, and players in the industry chain structure. The report answers various questions related current market []

Cancer Biomarkers Market is expected to reach $26,979.50 million by 2027 | Bio-Rad Laboratories, Inc.Thermo Fisher Scientific, Inc.Bristol-Myers Squibb CompanyExact Sciences Jun 14, 2021

The global cancer biomarkers market was valued at $10,944.08 million in 2019 and is expected to reach $26,979.50 million by 2027, registering a CAGR of 11.8% from 2020 to 2027. Cancer biomarkers are traceable substances or molecules that indicate the

Bio-Rad Laboratories Consensus Indicates Potential 25.2% Upside Jun 14, 2021

Bio-Rad Laboratories found using ticker (BIO) have now 4 analysts covering the stock. The analyst consensus points to a rating of ''Strong_Buy''. The target price ranges between 775 and 735 with the average target price sitting at 755. With the stocks previous close at 602.97 this would imply there is a potential upside of 25.2%. The day 50 moving average is 600.68 and the 200 day MA is 592.31. The company has a market cap of $17,796m. Visit the company website at: /> [stock_market_widget type="chart" symbol="BIO" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Bio-Rad Laboratories develops, manufactures, and markets life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.

Biomarkers Market With Leading Players like ThermFisher Scientific, QIAGEN Hologic, F. Hoffmann-La Roche Ltd, Janssen Global Services, LLC Siemens Healthcare GmbH, Cisbio, Biomarker Technologies, BD, Bio-Rad Laboratories, Jun 14, 2021

An off-the-shelf report on Biomarkers Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as type/components/

GMO Testing Market will Significantly Growth During 2021-2028- ALS Limited, AsureQuality, Bio-Rad Laboratories, Bureau Veritas, Eurofins Scientific, Intertek Group Jun 10, 2021

Increasing demand for processed foods through genetically modified Crops across the globe is driving the need for GMO testing market. Furthermore, evolution in the technology used in farming practices is also projected to influence the GMO testing market significantly. Growing consumer awareness about genetically modified foods in the developed nation is expected to fuel the GMO testing market. R1 Posted via Industry Today. Follow us on Twitter @IndustryToday

Bio-Rad Introduces Three StarBright Dyes for Flow Cytometry Jun 08, 2021

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today introduced three StarBright Dyes designed for flow cytometry applications.

The Global DNA Sequencing Market is Expected to Grow at a CAGR of 4.62% Between 2021 and 2028 - ResearchAndMarkets.com Jun 04, 2021

DUBLIN--(BUSINESS WIRE)--The "Global DNA Sequencing Market 2021-2028" report has been added to ResearchAndMarkets.com''s offering. After analyzing the global DNA sequencing market in detail, the publisher has put forth that this industry is likely to display an upward trend, with 4.62% of CAGR by revenue, over the forecasting years between 2021 and 2028. Companies Mentioned Adaptive Biotechnologies Inc Agilent Technologies Inc Asuragen Inc BGI Genomics Bio-Rad Laboratories Inc Danaher Corporatio

Bio-Rad Laboratories, Inc. v. International Trade Comm. (Fed. Cir. 2021) Jun 03, 2021

Last week, the Federal Circuit affirmed imposition of an exclusion order under 19 U.S.C. § 1337 (Section 337 of the Tariff Act of 1930) by the Federal Trade Commission against 10X Genomyx (an intervenor in this appeal) over importation of patented microfluidic chips, in Bio-Rad Laboratories, Inc. v. International Trade Commission. (10X Genomyx obtained a similar exclusion order against Bio-Rad in a case appealed last month; see "Bio-Rad Laboratories, Inc. v. Int''l. Trade Comm".) By: McDonnell Boehnen Hulbert & Berghoff LLP

Cell Analysis Global Market - Forecast to 2027: Focus on Consumables, Instruments & Software and Services Jun 01, 2021

DUBLIN , June 1, 2021 /PRNewswire/ -- The "Cell Analysis Global Market - Forecast to 2027" report has been added to ResearchAndMarkets.com''s offering. The cell analysis global market is expected to reach $33,542.0 million by 2027 growing at a mid-single-digit CAGR from 2020 to 2027 Market growth is due to rising incidence of infectious and non-infectious diseases and demand for early detection, diagnosis & treatment, increasing government and private funding, increasing advancements in cell imaging technologies to reduce the cost & time during the drug discovery process, growing focusing on personalized medicine, the introduction of advanced technologies in single-cell analysis and emerging Asia-Pacific market. However, stringent government regulations, lack of skilled personnel to use advanced cell analysis Instruments, and the high cost of some of the instruments are expected to hamper the market growth. The Asia-Pacific is the fastest-growing region in the cell analysis global market at a mid single-digit CAGR from 2020 to 2027 which is attributed to the increased scope for research activities in academic & research institutes, increasing outsourcing, increased incidence of chronic diseases (cancer) and infectious disease, increasing awareness about early screening (cancer) and prenatal test and their adoption in clinical care, increasing government and private investment for - cell-based research and also for the development & expansion single-cell analysis technologies and increasing number startup companies engaged in the development innovative solutions.

DGAP-Adhoc: Biotest AG: Ad-hoc RELEASE Announcement according to Article 17 European Market Abuse Regulation (MAR) Jun 01, 2021

DGAP-Ad-hoc: Biotest AG / Key word(s): Transaction in Own Shares Biotest AG: Ad-hoc RELEASE Announcement according to Article 17 European Market Abuse Regulation (MAR) 01-Jun-2021 / 12:12 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely

About

Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets.

CEO

Norman Schwartz

Employees

8000

Headquarters

1000 Alfred Nobel Dr , Hercules, California 94547-1811 US

Founded

1952